PATENT CLAIM ANALYSIS

Application Number: 15770443
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["424", "400000"]

Abstract:
Physically and chemically stable oral liquid formulations of Givinostat (Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride) are disclosed, together with methods for the preparation thereof. Such oral formulations are in the form of aqueous suspensions and contain Givinostat and/or pharmaceutically acceptable salts and/or derivatives thereof, at least a wetting agent and/or at least a density-imparting agent. Such formulations are suitable for oral administration for systemic therapeutic action.

Claim (Index 19):
The method according to  claim 18 , which treats disease responding to Givinostat selected from the group consisting of systemic juvenile idiopathic arthritis, polycythaemia vera, essential thrombocythemia, leukemias, myelomas, myelofibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy and other forms of muscular dystrophy.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 91.0
- Lexical Diversity: 1.48077
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14353141', '14994497', '13979997', '13138047', '15208957']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7437127275168308
- 35 USC 102 Novelty (BERT): 0.494795684294745
- Combined Prediction Score: 0.7188210231946223
- Mean Citation Score: 156.78560199999995
- Max Citation Score: 163.81133
- Similarity Product: 98.0131583919716

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test